Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Egetis Receives Approval In Turkey For Compassionate Use Of Emcitate For MCT8 Deficiency

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    09/09/2021 07:06
    Sept 9 (Reuters) - Egetis Therapeutics AB (publ)  EGTX.ST :
    * EGETIS RECEIVES APPROVAL IN TURKEY FOR COMPASSIONATE USE
OF
EMCITATE® FOR MCT8 DEFICIENCY

Source text for Eikon:  ID:nMFN8nw4zz 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news